NASDAQ:JYNTJoint Stock Price, Forecast & News

Joint's stock was trading at $13.61 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, JYNT stock has increased by 15.9% and is now trading at $15.78. View which stocks have been most impacted by Coronavirus.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Joint in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Joint.

Joint is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020. View our earnings forecast for Joint.

Joint Corp (NASDAQ:JYNT) posted its quarterly earnings results on Thursday, May, 7th. The company reported $0.06 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $0.07 by $0.01. The firm had revenue of $13.64 million for the quarter, compared to analyst estimates of $13.03 million. Joint had a return on equity of 66.44% and a net margin of 6.20%. View Joint's earnings history.

4 brokerages have issued 12-month target prices for Joint's shares. Their forecasts range from $20.00 to $32.00. On average, they expect Joint's stock price to reach $26.00 in the next twelve months. This suggests a possible upside of 64.8% from the stock's current price. View analysts' price targets for Joint.

News headlines about JYNT stock have been trending somewhat positive on Sunday, InfoTrie Sentiment Analysis reports. InfoTrie scores the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Joint earned a coverage optimism score of 1.0 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the near future. View the latest news aboutJoint.

Joint saw a drop in short interest in the month of May. As of May 15th, there was short interest totaling 1,940,000 shares, a drop of 6.7% from the April 30th total of 2,080,000 shares. Based on an average daily trading volume, of 157,900 shares, the short-interest ratio is presently 12.3 days. Approximately 14.8% of the shares of the stock are sold short. View Joint's Current Options Chain.

Some companies that are related to Joint include TiVo (TIVO), Digital Turbine (APPS), Liberty Tax (TAXA), Quarterhill (QTRHF), XpresSpa Group (XSPA), Research Frontiers (REFR), Acacia Research (ACTG), Quarterhill (QTRH), Finjan (FNJN), Marathon Patent Group (MARA), XCel Brands (XELB), MGT Capital Investments (MGTI), Health Discovery (HDVY), Spherix (SPEX) and ARC Group (ARCK). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Joint investors own include Aurora Cannabis (ACB), Advanced Micro Devices (AMD), Ring Energy (REI), Ring Energy (REI), Walt Disney (DIS), Starbucks (SBUX), Viking Therapeutics (VKTX), Adobe (ADBE), Catalyst Pharmaceuticals (CPRX) and Corbus Pharmaceuticals (CRBP).

(JYNT) raised $20 million in an initial public offering on Tuesday, November 11th 2014. The company issued 3,000,000 shares at a price of $6.50 per share. Roth Capital Partners and Feltl and Company served as the underwriters for the IPO and Sanders Morris Harris was co-manager.

Joint trades on the NASDAQ under the ticker symbol "JYNT."

Joint's stock is owned by many different institutional and retail investors. Top institutional shareholders include Bandera Partners LLC (12.07%), BlackRock Inc. (6.37%), Skylands Capital LLC (5.31%), Acadian Asset Management LLC (1.85%), State Street Corp (1.75%) and Geode Capital Management LLC (1.24%). Company insiders that own Joint stock include Bandera Partners Llc, Glenn J Krevlin, Jake Singleton, James H Amos Jr, John P Meloun, Peter D Holt and Ronald V Davella. View institutional ownership trends for Joint.

JYNT stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, Squarepoint Ops LLC, GSA Capital Partners LLP, Strs Ohio, Nuveen Asset Management LLC, Engineers Gate Manager LP, Russell Investments Group Ltd., and THB Asset Management. View insider buying and selling activity for Joint.

JYNT stock was acquired by a variety of institutional investors in the last quarter, including Bandera Partners LLC, Grandeur Peak Global Advisors LLC, Wasatch Advisors Inc., Skylands Capital LLC, Old Well Partners LLC, Scholtz & Company LLC, Two Sigma Investments LP, and Globeflex Capital L P. Company insiders that have bought Joint stock in the last two years include Bandera Partners Llc, Jake Singleton, James H Amos Jr, and Peter D Holt. View insider buying and selling activity for Joint.

Shares of JYNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of JYNT stock can currently be purchased for approximately $15.78.

Joint has a market capitalization of $219.97 million and generates $48.45 million in revenue each year. The company earns $3.32 million in net income (profit) each year or $0.23 on an earnings per share basis. Joint employs 138 workers across the globe.

The official website for Joint is www.thejoint.com.

Joint's mailing address is 16767 N PERIMETER DRIVE SUITE 240, SCOTTSDALE AZ, 85260. The company can be reached via phone at 480-245-5960 or via email at [email protected]